titan trial | investigating the addition of apalutamide to androgen deprivation therapy
Published 6 months ago • 729 plays • Length 31:13Download video MP4
Download video MP3
Similar videos
-
6:42
titan trial
-
3:06
titan trial
-
3:28
apalutamide and the titan clinical trial
-
8:33
titan phase 3 trial with apalutamide in metastatic castration sensitive prostate cancer
-
1:34
dr. chi on the titan trial results in metastatic castration-sensitive prostate cancer
-
3:04
researcher comment: apalutamide addition improves metastatic cspc survival | axel merseburger
-
2:50
live from asco: apalutamide for castration-sensitive prostate cancer
-
1:20
nancy a. dawson, md, discusses outcomes from the titan study in mcspc
-
1:38
kim n. chi, md, regarding key highlights from the final analysis of the phase iii titan study
-
1:28
apalutamide plus adt leads to survival benefit in mcspc
-
9:01
prostate cancer updates: titan and enzamet
-
12:42
pca commentary - nmcrpc and androgen receptor inhibition: enzalutamide, apalutamide and darolutamide
-
6:40
updated overall survival outcomes in enzamet (anzup 1304)
-
1:50
dr. agarwal on pfs2 data from the titan trial in mcspc
-
13:05
titan: update on the data and where next for patients with hormone sensitive pc
-
0:18
the #innovate trial is for patients with node-positive #prostatecancer.
-
1:23
dr. saad on the safety profile of apalutamide in m0crpc